SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
ARIAD Pharmaceuticals
An SI Board Since September 1996
Posts SubjectMarks Bans Symbol
4474 134 0 ARIA
Emcee:  jaybe Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
4399Interesting leukemia study may help identify candidates for earlier treatment. floWteiuQ-10/3/2016
4398Spirit3 trial terminated, or more precisely cancelled... A few reasons cited, Ijaybe39/30/2016
4397I suspect they are simply playing out Iclusig for maximum value. That's all.floWteiuQ-9/29/2016
4396Hi jesspro. I expect you don't realize this, but take a guess on the number tktom-9/27/2016
4395Tktom, I was just wondering if there is anything funny about BioMaven's commjesspro-9/27/2016
4394I've really hoped someone would take this further - maybe this new article wtktom-9/27/2016
4393This is a follow-on to this Roche article from a few years back showing pona comBiomaven-9/26/2016
4392Jaybe, have you seen this article yet? It came out in June 2016 but it's Grejesspro-9/26/2016
4391they are not suggesting that lower doses cause higher event rates. They clearlyCrazyPete-9/26/2016
4390Thanks Jaybe.jesspro-9/23/2016
4389Its not new, these results were presented at EHA 2016 (Abstract E1110) in June. jaybe-9/23/2016
4388While we await a reply from Jaybe/BioM I will weigh in .IMHO this is bogus and pcivic08801-9/23/2016
4387Jaybe/BioM, does this new report make sense to you guys that lower dosage of Icljesspro-9/23/2016
4386I am sure this deal has not escaped Denner's attention..Think About It,Verycivic08801-9/20/2016
4385Cramer used to work for GS and the Hit Article yesterday was directed by GS who civic0880119/20/2016
4384Just another example of how Jim Cramer worked hand in hand with GS and Crashed Acivic08801-9/19/2016
4383Definitely not a BCL-2 inhibitor in the works. This MD Anderson study used venjaybe29/8/2016
4382Jaybe, does ariad have a bcl-2 inhibitor? I asked because of this article belowjesspro-9/8/2016
4381Standard practice, and in this case already filed. The "crystalline" fjaybe-8/30/2016
4380I mean 8 to 12 years ago...jesspro-8/30/2016
4379Jaybe/BioM, the formula for Iclusig has probably been patented at least 8/ 12 ajesspro-8/30/2016
4378Some good news this morning, but not too much of an spike. <g> businesswirJibacoa-8/30/2016
4377Here is an update on potential to further explorer nilotinib in Parkinson's ghmm-8/30/2016
4376Second IST for pona in FLT3-ITD AML now enrolling... Australian group (ALLG) wijaybe-8/28/2016
4375Pre-clinical evidence for pona in neuroblastoma... "In conclusion, ponatinjaybe-8/27/2016
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News